| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 23.041 | 25.095 | 14.553 | 20.542 | 29.448 | 31.137 | 29.395 |
| Total Income - EUR | 0 | 0 | 0 | 23.418 | 27.574 | 14.899 | 20.542 | 29.448 | 31.137 | 29.395 |
| Total Expenses - EUR | 0 | 0 | 0 | 19.081 | 19.724 | 13.321 | 16.544 | 17.503 | 22.625 | 33.660 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 4.337 | 7.851 | 1.577 | 3.998 | 11.946 | 8.512 | -4.265 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 4.103 | 7.576 | 1.432 | 3.793 | 11.653 | 8.201 | -4.559 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Flormed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 2.905 | 6.375 | 5.344 | 3.649 | 2.545 | 0 | 1.077 |
| Current Assets | 0 | 0 | 0 | 10.419 | 5.888 | 5.647 | 7.203 | 17.916 | 16.441 | 10.436 |
| Inventories | 0 | 0 | 0 | 74 | 67 | 90 | 79 | 224 | 98 | 890 |
| Receivables | 0 | 0 | 0 | 6.110 | 547 | 1.026 | 1.213 | 1.502 | 1.949 | 3.791 |
| Cash | 0 | 0 | 0 | 4.235 | 5.275 | 4.532 | 5.911 | 16.190 | 14.394 | 5.754 |
| Shareholders Funds | 0 | 0 | 0 | -18.463 | -10.530 | -8.898 | -4.908 | 6.853 | 15.033 | 10.493 |
| Social Capital | 0 | 0 | 0 | 790 | 775 | 760 | 743 | 745 | 743 | 739 |
| Debts | 0 | 0 | 0 | 31.787 | 22.792 | 19.889 | 15.759 | 13.607 | 1.408 | 1.020 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5590
|
|||||||||
Comments - Flormed S.r.l.